Winstrol: Oral vs Injectable (Stanozolol)

Winstrol (stanozolol) comes in two forms that share the same parent compound but differ in how they are delivered and how long they last. The short answer: oral Winstrol has a 9-hour half-life and carries moderate hepatotoxicity, while injectable Winstrol (a water-based microcrystal suspension, not an oil ester) has an 82-hour apparent half-life and mild hepatotoxicity. Both are DHT derivatives that do not aromatize, both are used as cutting agents, and both are notorious for joint pain and HDL suppression.

The parent compound: what stanozolol does

Stanozolol is a DHT derivative with an added pyrazole ring, developed in 1962. It binds the androgen receptor and produces strength and hardness without estrogenic water retention, since it cannot aromatize. It is already a DHT derivative, so it is not further 5-alpha-reduced.

One distinctive feature: stanozolol lowers sex hormone-binding globulin (SHBG) significantly. Lower SHBG raises the free fraction of any co-administered hormone, including testosterone. This is a real interaction effect. If you stack Winstrol with a testosterone base, your free testosterone rises more than the total dose suggests. This can be useful, and it can also amplify androgenic side effects.

HPTA suppression is rapid and dose-dependent. Detection is well characterized and long, which we cover below.

Oral Winstrol

Winstrol (Oral) is a 17-alpha-alkylated tablet. The dataset records a half-life of 9 hours and nominal bioavailability near 100%. That short half-life drives the standard twice-daily split dosing used in documented protocols.

Hepatotoxicity is rated moderate, comparable to Dianabol. Liver enzyme monitoring applies. The 17-alpha-methyl group is the mechanism, same as other oral AAS.

Detection: the 3′-hydroxystanozolol-O-glucuronide metabolite is detectable for roughly 21 to 42 days after the last oral dose (Schänzer et al., 2013).

Injectable Winstrol (Winstrol Depot)

Winstrol (Injectable) is not an oil-based ester like most injectables. It is a water-based microcrystal suspension. Those microcrystals dissolve slowly at the injection site, which gives the depot its extended release and its unusually long apparent peak.

The dataset records a half-life of about 82 hours (3.4 days), Cmax near 600 ng/dL, and 100% nominal bioavailability. Documented protocols injected every other day to match that depot profile.

Hepatotoxicity is rated mild for the injectable, lower than the oral form, because it avoids first-pass metabolism. Liver enzyme monitoring still makes sense but the risk is meaningfully lower.

Detection: the microcrystal depot extends detection roughly 2 to 3 times compared to oral, because the compound keeps releasing from the injection site. The same glucuronide metabolites are the target analytes. Plan for roughly 42 to 63 days after the last injectable dose.

Joint pain and the dry effect

This is the most commonly reported downside of Winstrol in both forms. Because it does not aromatize and produces no water retention, it reduces synovial and subcutaneous water. Users report dry, cracking joints and pain during heavy lifting, especially in shoulders, knees, and elbows.

This is not a minor side effect. Training heavy on Winstrol with dry joints is a recipe for tendon and ligament injury. Some users stack it with a low dose of a mildly estrogenic compound like nandrolone to offset the dryness, but that adds another compound and its own monitoring needs.

If you are using Winstrol, plan training around the joint effect. Higher reps, controlled eccentrics, and avoiding 1RM attempts are reasonable. This is harm reduction at the training level.

Lipids: the main cardiovascular concern

Like many oral AAS, Winstrol suppresses HDL and can raise LDL. This effect is noted as particularly pronounced with stanozolol in the literature. The cardiovascular risk from a wrecked lipid panel is real and cumulative.

A lipid panel before, during, and after any Winstrol run is essential. If HDL crashes badly, shortening the run or stopping is the right call. The injectable form may be somewhat gentler on lipids than the oral, but both shift the panel in the wrong direction.

FAQ

Is injectable Winstrol safer than oral?

Somewhat. The injectable avoids first-pass metabolism, so hepatotoxicity is rated mild vs moderate for the oral. But the joint pain, lipid shifts, and androgenic effects are comparable. And the injectable has a longer detection window because the depot keeps releasing.

Why does Winstrol cause joint pain?

Winstrol does not aromatize, so there is no water retention or synovial lubrication from estrogenic activity. The drying effect makes joints feel brittle. This is a pharmacological consequence of a non-aromatizing DHT derivative, not a contamination issue.

How long is Winstrol detectable?

Oral: roughly 21 to 42 days via the 3′-hydroxystanozolol-O-glucuronide metabolite (Schänzer 2013). Injectable: roughly 42 to 63 days, because the microcrystal depot extends release. This is for educational context, not test-beating guidance.

Does Winstrol lower SHBG?

Yes, significantly. Lower SHBG raises the free fraction of co-administered hormones like testosterone. This is a real interaction effect that can amplify both results and side effects when Winstrol is stacked.

Can women use Winstrol?

It is used by some women because it does not aromatize, but virilization risk is real (voice deepening, hair growth, clitoral changes) and can be irreversible. Lowest effective dose and immediate stopping if any sign appears is the approach. See our first cycle guide.

Sources

• Schänzer W, et al. Metabolism of stanozolol: detection of new metabolites. Drug Testing and Analysis. 2013;5:810. PubMed
• World Anti-Doping Agency. Prohibited List. wada-ama.org.
• Kam PCA, Yarrow M. Anabolic steroid adverse effects. British Journal of Sports Medicine.
• Sjöqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. The Lancet.